Currently, CVS Health has a Zacks Rank #3 (Hold) but that could change following its third quarter 2016 earnings report which has just released.
CVS Health Corporation (NYSE:CVS) will announce its Q316 earnings results on Tuesday, November 8th. CVS Health Corporation's dividend payout ratio is now 39.08%. Leerink Swann reaffirmed an "outperform" rating and issued a $105.00 target price (down from $110.00) on shares of CVS Health Corporation in a research report on Sunday, October 2nd. The retail and long-term care unit had a 12.5 percent revenue boost to $20.1 billion, mainly on operations within Omnicare, a long-term care facility unit that CVS bought in 2015. UBS Asset Management Americas Inc.'s holdings in CVS Health Corporation were worth $464,915,000 as of its most recent filing with the SEC. CVS Health Corp makes up approx 0.84% of Pension fund Dsm Netherlands's portfolio.First American Trust FSB reduced its stake in
First American Trust FSB reduced its stake in CVS by selling 3,646 shares or 34.13% in the most recent quarter. FBR & Co reiterated an "outperform" rating and set a $120.00 price target on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Annex Advisory Services LLC now owns 2,184 shares of the pharmacy operator's stock valued at $209,000 after buying an additional 96 shares during the period. Alexandria Capital LLC now owns 1,405 shares of the pharmacy operator's stock worth $135,000 after buying an additional 46 shares during the period. The stock presently has an average rating of "Buy" and a consensus target price of $111.24. Kelly Lawrence W & Associates Inc.
CVS Health Corporation (NYSE:CVS) traded up 0.91% during midday trading on Friday, reaching $82.31.
The bulk of the revenue boost came from the pharmacy benefits unit, with an increase of 19.2 percent to $4.9 billion. The Hedge Fund company now holds 27,600 shares of CVS which is valued at $2,317,020.
CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company.
Major Factors: CVS Health ended the third quarter of 2016 on a mixed note, with its bottom-line exceeding the Zacks Consensus Estimate, while the top line missing the same. Moreover, management narrowed the company's 2016 adjusted EPS guidance, which disappoints us. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/care mark Pharmacy Services Novologix and Navarro Health Services names.